COMP <GO>
SNWV vs XTNT // EV/EBITDA & P/E VALUATION
SANUWAVE Health Inc. (NASDAQ) VS. Xtant Medical Holdings Inc. (NYSE) • 15-METRIC TALLY: SNWV 7
— XTNT 3
▲ EV/EBITDA & P/E VALUATION LEADER: XTNT
LAST: $5.27 (0.00%) • MKT CAP: $45.3M
valuation
7.5x
LAST: $0.29 (+1.54%) • MKT CAP: $40.7M
valuation
3.7x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SNWV VS. XTNT)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | SNWV | XTNT | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 77.10% | 62.90% | +14.20 | SNWV | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 67.30% | 12.80% | +54.50 | SNWV | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 7.5x | 3.7x | +3.80 | XTNT | /valuation <GO> |
| Free Cash Flow Yield | 4.27% | 24.95% | -20.68 | XTNT | /fcf-yield <GO> |
| Operating Margin | 11.20% | 5.40% | +5.80 | SNWV | /operating-margins <GO> |
| Net Profit Margin | 26.80% | 0.00% | +26.80 | SNWV | /net-margins <GO> |
| Revenue Growth (YoY) | 36.30% | 14.20% | +22.10 | SNWV | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 0.20 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 9/9 | -2.00 | XTNT | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 50.4 | 34.9 | +15.42 | SNWV | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 3.5x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $45.3M | $40.7M | $4.6M | SNWV | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | SNWV REV | XTNT REV | SNWV GROSS % | XTNT GROSS % | SNWV FCF | XTNT FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $44.1M | $133.9M | 77.1% | 62.9% | $1.9M | $10.2M |
| FY 2024 | $32.3M | $117.3M | 75.9% | 58.2% | $2.0M | -$16.0M |
| FY 2023 | $19.3M | $91.3M | — | — | -$4.5M | -$9.5M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SNWV // BETA —
XTNT // BETA —